Adalimumab reduces inflammation in refractory pediatric uveitis
A new study published in the current issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) suggests that the biologic agent adalimumab may be a viable treatment option for patients ...
Oct 22, 2013
0
0